These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6801270)

  • 41. Long-term followup after endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer in patients with neurogenic bladder.
    Polackwich AS; Skoog SJ; Austin JC
    J Urol; 2012 Oct; 188(4 Suppl):1511-5. PubMed ID: 22910250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serious complications following topical administration of thio-tepa in a patient with bladder carcinoma].
    Kaczmarek A
    Wiad Lek; 1978 Apr; 31(8):547-50. PubMed ID: 96607
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of oxybutynin on vesicoureteral reflux in children.
    Homsy YL; Nsouli I; Hamburger B; Laberge I; Schick E
    J Urol; 1985 Dec; 134(6):1168-71. PubMed ID: 4057409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer].
    Nishio Y; Kaku S; Hida S; Ohishi K; Okada Y; Yoshida O
    Hinyokika Kiyo; 1988 Sep; 34(9):1593-9. PubMed ID: 3213794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe pancytopenia associated with the use of intravesical thio-TEPA.
    Watkins WE; Kozak JA; Flanagan MJ
    J Urol; 1967 Oct; 98(4):470-1. PubMed ID: 4964489
    [No Abstract]   [Full Text] [Related]  

  • 46. Fate of vesicoureteral reflux in children with neuropathic bladders managed by intermittent catheterization.
    Kass EJ; Koff SA; Diokno AC
    J Urol; 1981 Jan; 125(1):63-4. PubMed ID: 7463586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin.
    Hillyard RW; Ladaga L; Schellhammer PF
    J Urol; 1988 Feb; 139(2):290-3. PubMed ID: 3339727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The management of vesicoureteral reflux in children with myelodysplasia.
    Bauer SB; Colodny AH; Retik AB
    J Urol; 1982 Jul; 128(1):102-5. PubMed ID: 7109042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vesicoureteral reflux in women with primary bladder diverticulum.
    Amar AD; Das S
    J Urol; 1985 Jul; 134(1):33-5. PubMed ID: 3925167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thiotepa-induced myelosuppression: review of 670 bladder instillations.
    Soloway MS; Ford KS
    J Urol; 1983 Nov; 130(5):889-91. PubMed ID: 6415297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The PIC cystogram: a novel approach to identify "occult" vesicoureteral reflux in children with febrile urinary tract infections.
    Rubenstein JN; Maizels M; Kim SC; Houston JT
    J Urol; 2003 Jun; 169(6):2339-43. PubMed ID: 12771795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Incidence of vesico-ureteral reflux after endoscopic surgery of superficial tumors of the bladder. A prospective study].
    Ricos Torrent JV; Casanova Ramón-Borja J; Iborra Juan I; Monros Lliso JL; Mazcuñán Fuentes F; Dumont Martínez R; Solsona Narbón E
    Arch Esp Urol; 1990 Mar; 43(2):136-9; discussion 140. PubMed ID: 2363578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vesico-ureteral reflux following transurethral resection of bladder carcinoma].
    Míguez Codesido M; Chantada Abal V; Lancina Martín JA; González Martín M
    Arch Esp Urol; 1984; 37(5):419-24. PubMed ID: 6517627
    [No Abstract]   [Full Text] [Related]  

  • 54. The management of vesicoureteral reflux in the pediatric neurogenic bladder.
    Sullivan T; Purcell MM; Gregory JG
    J Urol; 1981 Jan; 125(1):65-6. PubMed ID: 7463587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vesicoureteral reflux and voiding dysfunction: a prospective study.
    Seruca H
    J Urol; 1989 Aug; 142(2 Pt 2):494-8; discussion 501. PubMed ID: 2746764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide.
    Bruce D; Edgcomb JH
    J Urol; 1967 Mar; 97(3):482-5. PubMed ID: 4960046
    [No Abstract]   [Full Text] [Related]  

  • 57. Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management.
    Herr HW; Whitmore WF
    J Urol; 1987 Aug; 138(2):292-4. PubMed ID: 3599241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa.
    Wood DP; Streem SB; Levin HS
    J Urol; 1988 Jan; 139(1):130-1. PubMed ID: 3121867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
    Horn Y; Eidelman A; Walach N; Ilian M
    J Urol; 1981 May; 125(5):652-4. PubMed ID: 6785455
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial.
    Zincke H; Utz DC; Taylor WF; Myers RP; Leary FJ
    J Urol; 1983 Mar; 129(3):505-9. PubMed ID: 6403716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.